Shockwave Medical to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021

Rhea-AI Summary

Shockwave Medical, Inc. (Nasdaq: SWAV) will report its financial results for the fourth quarter and full year 2020 on February 17, 2021, after market close. A conference call for investors is scheduled for 1:30 p.m. PT / 4:30 p.m. ET. Investors can participate via a domestic line at (866) 795-9106 or international line at (470) 495-9173, using conference ID: 7854854. The call will also be available through a live and archived webcast on the company's investor relations website.

Positive

• The company's focus on Intravascular Lithotripsy (IVL) positions it uniquely in the cardiovascular treatment market.
• IVL technology aims to improve patient outcomes and could establish a new standard of care.

Negative

• None.

SANTA CLARA, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced it will report financial results for the fourth quarter and full year 2020 after market close on Wednesday, February 17, 2021. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.  

Investors interested in listening to the conference call may do so by dialing (866) 795-9106 for domestic callers or (470) 495-9173 for international callers, using conference ID: 7854854. A live and archived webcast of the event will be available at https://ir.shockwavemedical.com.

About Shockwave Medical, Inc.
Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.

Media Contact:
Scott Shadiow
+1.317.432.9210
sshadiow@shockwavemedical.com

Investor Contact:
Debbie Kaster
dkaster@shockwavemedical.com

FAQ

When will Shockwave Medical report its financial results for 2020?

Shockwave Medical will report its financial results for the fourth quarter and full year 2020 on February 17, 2021.

What is the conference call date and time for Shockwave Medical's financial results?

The conference call will take place on February 17, 2021, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

How can I listen to the conference call for Shockwave Medical's financial results?

Investors can listen to the conference call by calling (866) 795-9106 for domestic callers or (470) 495-9173 for international callers, using conference ID: 7854854.

Where can I find the archived webcast of Shockwave Medical's conference call?

The archived webcast will be available on the company's investor relations website.